Наркомания. Нейропептид Морфиновые рецепторы - Зайцев С.В.
ISBN 5-211-02349-8
Скачать (прямая ссылка):
Sandler М., Carter B.S., Hunter H.R. et al. Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man // Nature. 1973. V. 241. N 5390. P. 439-443.
Sanghvi I.S., Gerson S. Brain calcium and morphine action // Biochem. Pharmacol. 1977. V. 26. N 13. P. 1181-1185.
Samovilova N.N., Nagornaya L.V., Vinogradov V.A. (+)-[3H]SK&f 10,047 binding sites in rat liver // Europ. J. Pharmacol. 1988. V. 147. N 2. P. 259-264.
Sanders D.A., Koshland D.E. Receptor interactions through phospho-rylationand methylation pathways in bacterial chemotaxis // Proc. Natl. Acad. Sci. USA. 1988. V. 85. P. 8425-8429.
Sarcar R., Nichtenhauser R., Ieni J.R., Zukin S.R. Characterization and autoradiographic visualization of (+)-[3H] SKF 10047 binding in rat and mouse brain: further evidence for phencyclidine ”sigma opiate” receptor commonality // J. Pharmacol. Exp. Ther. 1986. V. 237. N 2. P. 681-688.
Satch М., Zieglgansberger W., Herz A. Actions of opiates upon single unit activity in the cortex of naive and tolerant rats j j Brain Res.
1976. V. 115. N 1. P. 99-108.
Sato Т., Hashizume Т., Nakao M. et al. Platelet desensitization by
arachidonic acid is associated with the suppression of endoperox-
ide/tromboxane Ao binding to the membrane receptor // Biochim. Biophys. Acta. 1989. V. 992. N 2. P. 168 173.
Sato H., Sugiyama Y., Sawada Y. et al. Pharmacokinetic study of exogenously administered -endorphin using a rapid radioreceptor assay in rats // Life Sci. 1984. V. 35. N 10. P. 1051-1059.
Scatchard G. The allractions of proteins for small molecules and ions 11 Ann. N.Y. Acad. Sci. 1949. V. 51. P. 660-672.
Schaumann W. The paralysing action of morphine on the guinea pig
ileum. // Br. J. Pharmacol. 1955. V. 10. N 4. P. 456-461.
Schepp W., Schneider J., Schusdziarra V. Naturally occurring opioid peptide modulate H+-production by isolated rat parietal cells // Peptides. 1986. V. 7. N 5. P. 885-890.
Schiller P.W., DiMaio J. Opiate receptor subclasses differ in their conformational requirements // Nature. 1982. V. 297. N 5861.
P. 74-76.
Schiller P.W., Nguyen T.M.-D., Maziak L. et al. A novel cyclic opioid peptide analog showing high preference for ^-receptors // Biochem. Biophys. Res. Communs. 1985. V. 127. N 2. P. 558-564.
Schofield P.R., Abbott A. Molecular pharmacology and drug action: structural information casts light on ligand binding // Trends in Pharm. Sci. 1989. V. 10. N 6. P. 207-212.
Schlessinger J. Signal transduction by allosteric receptor oligomerization // Trends in Biochem. Sci. 1988. V. 13. P. 443-447.
Schultzberg М., Hokfelt T. The mismatch problem in receptor autoradiography and the coexistence of multiple messengers // Trends Neurosci.
1986. V. 9. N 3. P. 109-110.
Schulz R., Wuster М., Herz A. Pharmacological characterization of the
epsilon-opiate receptor j j J. Pharmacol. Exp. Ther. 1981. V. 216. N 3. P. 604-606.
Schwartz J.-C., Malfroy B., De La Baume S. Biological inactivation of enkephalins and the role of enkephalin - dipeptidylcarboxypeptidase (’’enkphlinase”) as neuropeptidase // Life Sci. 1981. V. 29. P. 1715-1740.
Schweigerer L., Bhakdi J., Teschemacher H. Specific nonopiate sites for human beta-endorphin on the terminal complex of human complement // Nature. 1982. V. 296. N 5857. P. 572-574.
Seisinger B.R., Bovermann K., Holh V. et al. Enhanced activity of the
endorphinergic system in the anterior and neurointermediate lobe of the rat pituitary gland after chronic treatment with ethanol liquid diet // J. Pharmac. Exp. Ther. 1984. V. 230. P. 455-461.
Seisinger B.R., Hollt V., Herz A. Effects of chronic ethanol treatment on the in vitro biosynthesis of pro-opiomelanocortion and its post-translational processing to /2-endorphin in the intermediate lobe of the rat pituitary // J. Neurochem. 1984. V. 43. N 3. P. 607-613.
Sharabani М., Plotkin B., Aviram I. Lipid peroxidation in red blood cell membranes // Cell. Mol. Biol. 1984. V. 30. N 4. P. 329-336.
Sharma S.K., Nirenberg М., Klee W.A. Morphine receptors as regulators of adenilate cyclase activity // Proc. Natl. Acad. Sci. USA. 1975. V. 72. N 2. P. 590-594.
Shearman G.T., Herz A. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10047) in the rat // Europ. J. Pharmacol. 1982. V. 82. N 3-4. P. 167-172.
Shenolikar S. Protein phosphoryltion: hormones, drugs and bioregulation // FASEB J. 1988. V. 2. P. 2753-2764.
Shimohigashi Y., Costa Т., Stammer C.H. Dehydroenkephalin receptor binding activity of unsaturated analogs of Leu5-enkephaliri // FEBS Lett. 1981. V. 133. N 2. P. 269-271.
Shulz R., Wuster М.. Duka T. et al. Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary // Psychopharmacology. 1980. V. 68. N 2. P. 221-226.
Sibley D.R., Lefkowits J. Molecular mechanisms of receptor desensitization using the /^-adrenergic receptor-coupled adenylate cyclase system as a model j j Nature. 1985. V. 317. N 6033. P. 124-129.
